Position in TLRY
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$1,491,354
-$507,915 QoQ
Shares Held
230,503
+4.1% QoQ
Ownership
0.198%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TLRY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Swiss National Bank holds $531,346,390 across 28 Drug Manufacturers - Specialty & Generic names. TLRY ranks #26 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,293,332 | $152,884,775 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
4,227,900 | $127,344,348 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
120,055 | $71,190,213 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
292,600 | $38,547,124 | |
| 5 | VTRS |
Viatris Inc
|
2,279,402 | $30,794,721 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
983,392 | $23,532,570 | |
| 7 | ALKS |
Alkermes plc.
|
310,300 | $10,972,208 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
131,154 | $9,948,030 |
All Filings in TLRY
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,491,354 | 230,503 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,999,269 | 221,403 | Shares | Sole | 2026-02-12 | |
| No filing history on record for this holder in this stock. | ||||||